• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s R&D focuses on vaccines addressing high unmet medical needs.

  • Valneva covers the full value chain from research to market.

Welcome to Valneva
A fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines.

ABR_Website_Image.jpg

— November 9, 2017

Valneva Reports Strong Operational Performance for the First Nine Months of 2017

Read more

— Stock information

@valnevase




















-
— July 26, 2017
Valneva and Emergent BioSolutions Join Forces to Develop a Vaccine against the Zika Virus

Read more
— Financial Calendar

November 9, 2017
9M 2017 Interim Results
Analyst Presentation
Webcast

February 15, 2018
Preliminary 2017 Results (Revenues, Cash)

March 22, 2018
2017 Financial Statements

May 17, 2018
Q1 2018 Interim Results

See all dates






JAPANESE
ENCEPHALITIS
AND
CHOLERA



learn more
play video Company Video

– Upcoming conferences



Jefferies 2017 Global Healthcare Conference
London, UK
November 15-16, 2017

21st World Congress and Exhibition on Vaccines, Vaccination & Immunization

Vienna, Austria
November 16-17, 2017


 
Please update your browser...